Daniel Saporito, DPM
Foot & Ankle Surgery · Kingston, PANPI 1750542205
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 4 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 4 manufacturers reported payments, led by Novus Surgical Solutions LLC at 39.9% of the total. Reporting peaked in 2019 at $49 and has fallen 75.9% since, to $12 in 2022. That places this record below the midpoint for foot & ankle surgery clinicians in PA, where the typical reported total is $2,232.
Across 4 payments — averaging $19.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novus Surgical Solutions LLC$31
- Melinta Therapeutics, LLC$18
- Smith+Nephew$16
- GRT US Holding, Inc.$12
What the payments were for
- Food & beverage$78100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novus Surgical Solutions LLC | 1 | $31 |
| Melinta Therapeutics, LLC | 1 | $18 |
| Smith+Nephew | 1 | $16 |
| GRT US Holding, Inc. | 1 | $12 |
How this compares
$78 in reported general payments places this provider in the 5th percentile of 575 foot & ankle surgery providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Methylprednisolone | 132 | $887 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 34 | $741 |
| Pregabalin | 17 | $526 |
| Ammonium Lactate | 31 | $521 |
| Gabapentin | 37 | $287 |
| Diclofenac Sodium | 19 | $248 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 61 | $238 |
| Ciclopirox | 12 | $212 |
| Cephalexin | 35 | $201 |
| Tramadol Hcl | 48 | $179 |
| Clindamycin Hcl | 23 | $148 |
| Prednisone | 24 | $141 |
| Ciprofloxacin Hcl | 15 | $122 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 15 | $120 |
| Levofloxacin | 22 | $111 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Kingston
- William DecarboBelle Vernon$3.5M
- David PedowitzBryn Mawr$1.6M
- Noman SiddiquiScranton$1.3M
- Peter MangonePittsburgh$1.1M
- Stephen BrigidoBethlehem$656K
- Guido LaportaDunmore$625K
- Adam TeichmanAllentown$545K
- Thomas RocchioAllentown$524K
- Jason MillerMalvern$501K
- James SferraCranberry Township$451K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.